Take the 12-Day


January 2-14, 2022

Get $500 Off Until December 17th!

Take the 12-Day


January 2-14, 2022

Get $500 Off Until
December 17th!

  1. Home
  2. The Longevity Challenge

What is the Longevity Challenge™?

A two-week challenge to help reverse the symptoms of obesity, chronic pain, inflammation, high blood pressure, diabetes, cognitive decline, and aging.

Flexible Scheduling

All services are available throughout the day to accomodate your work and personal schedules.

The Challenge

12 days of hyperbaric oxygen therapy, nutritional optimization, and supplements, selected & monitored by medical professionals to improve your health.


The Results

Significant weight loss, detoxification, reduced inflammation, pain relief, anti-aging effects, and more – after just 2 WEEKS!

What are Peoples Experiences?

What is Included?

Hyperbaric Oxygen Treatments (HBOT)

All participants will complete a total of 10 HBOT sessions during the 2-week challenge.

HBOT increases the available oxygen in your body by 10-15 times the normal concentration, helping your body reduce inflammation, repair and enhance your tissues, and reverse the effects of aging(1-3). It also has proven benefits for neurological conditions (TBI, Concussion, PTSD), GI disorders, autoimmune diseases, and more.

Nutrition Optimization

Participants may choose between the two options below for the duration of the Longevity Challenge:

  • Option 1: Zero Calorie Water Fast
  • Option 2: Intermittent fasting & Whole30

Both options can help you lose weight, decrease inflammation, detoxify your body, and reduce your risk of many diseases including heart disease, diabetes, and cancer(4-11).

Supplement Regimen

All participants will be provided their own bottle of our physician grade ProImmune supplement. Its patented Immune Formulation 200 is a composition of amino acids proven to increases levels of the glutathione in your body.

Glutathione helps regulate your immune response, reduce oxidative stress (which increases your risk of countless diseases), and can even reverse effects of aging(12-13).

Nutritional IV Therapy in Durham, NC

Myers' Nutritional IV’s

The Myers’ Cocktail IV includes magnesium, calcium, vitamin B complex, additional vitamin B5, B6, and B12, and Vitamin C.

It has proven benefits for boosting energy/reducing fatigue, decreasing inflammation, relieving joint and muscle pain, and improving brain health(14-19).

QEEG Brain Mapping & Biomarker Testing

QEEG Brain Mapping uses non-invasive QEEG recording to detect abnormal brain activity. Biomarker testing can provide measurable markers that allow us to monitor inflammation and cellular aging.

Participants who choose to do the Full Longevity Challenge will receive QEEG Brain Mapping & Biomarker Testing to provide a before and after snapshot of your health and monitor benefits that occur during the Longevity Challenge.

Personalized Longevity Success Plan

Don’t stop here! To ensure you’re continued health success, at the end of the Longevity Challenge, all participants will be given a personalized 12 Month Longevity Success Plan to help you sustain and build upon the improvements made during the challenge.

Your personalized plan will include recommendations and a schedule for therapies, supplements, and nutrition for the next year.

Longevity Challenge Pricing

*Water Fast Participants will be provided with liquid minerals and gallon jugs.
**Intermittent Fasting/Whole30 participants may choose to cook their own food or receive 10 to 20 Whole30 meals provided by Clean Eatz (a third party) for an additional $100-200. Requires minimum number of participants.
***Military Discount Available.

Additional Information

What is Hyperbaric Oxygen Therapy? (HBOT)

“In hyperbaric oxygen therapy, a patient breathes almost pure oxygen in a pressurized room or tube. By bringing more oxygen into the bloodstream, the treatment is thought to enhance healing for people with a number of conditions.”
– Medical News Today

10% of Profits Benefit Veterans

We are a veteran owned company, and we believe strongly in giving back to the men and women who fight for our freedom. 10% of the profits from the 12 Day Longevity Challenge will be used to provide free treatments to veterans.
  1. Thom, Stephen R. “Hyperbaric Oxygen – Its Mechanisms and Efficacy.” Plastic and Reconstructive Surgery, vol. 127, no. Suppl 1, Jan. 2011, pp. 131S-141S. PubMed Central, doi:10.1097/PRS.0b013e3181fbe2bf.
  2. Thom, Stephen R., et al. “Stem Cell Mobilization by Hyperbaric Oxygen.” American Journal of Physiology-Heart and Circulatory Physiology, vol. 290, no. 4, Apr. 2006, pp. H1378–86. physiology.org (Atypon), doi:10.1152/ajpheart.00888.2005.
  3. Hachmo, Yafit, et al. “Hyperbaric Oxygen Therapy Increases Telomere Length and Decreases Immunosenescence in Isolated Blood Cells: A Prospective Trial.” Aging, vol. 12, no. 22, Nov. 2020, pp. 22445–56. PubMed, doi:10.18632/aging.202188.
  4. Kerndt, P. R., et al. “Fasting: The History, Pathophysiology and Complications.” The Western Journal of Medicine, vol. 137, no. 5, Nov. 1982, pp. 379–99.
  5. Pedersen, C. R., et al. “Intermittent Feeding and Fasting Reduces Diabetes Incidence in BB Rats.” Autoimmunity, vol. 30, no. 4, 1999, pp. 243–50. PubMed, doi:10.3109/08916939908993805.
  6. Mah, Li Yen, and Kevin M. Ryan. “Autophagy and Cancer.” Cold Spring Harbor Perspectives in Biology, vol. 4, no. 1, Jan. 2012. PubMed Central, doi:10.1101/cshperspect.a008821.
  7. Zare-shahabadi, Ameneh, et al. “Autophagy in Alzheimer’s Disease.” Reviews in the Neurosciences, vol. 26, no. 4, 2015, pp. 385–95. PubMed Central, doi:10.1515/revneuro-2014-0076.
  8. Johnstone, A. “Fasting for Weight Loss: An Effective Strategy or Latest Dieting Trend?” International Journal of Obesity (2005), vol. 39, no. 5, May 2015, pp. 727–33. PubMed, doi:10.1038/ijo.2014.214.
  9. Johnstone, A. “Fasting for Weight Loss: An Effective Strategy or Latest Dieting Trend?” International Journal of Obesity (2005), vol. 39, no. 5, May 2015, pp. 727–33. PubMed, doi:10.1038/ijo.2014.214.
  10. Mattson, Mark P., and Ruiqian Wan. “Beneficial Effects of Intermittent Fasting and Caloric Restriction on the Cardiovascular and Cerebrovascular Systems.” The Journal of Nutritional Biochemistry, vol. 16, no. 3, Mar. 2005, pp. 129–37. ScienceDirect, doi:10.1016/j.jnutbio.2004.12.007.
  11. Aksungar, Fehime B., et al. “Interleukin-6, C-Reactive Protein and Biochemical Parameters during Prolonged Intermittent Fasting.” Annals of Nutrition & Metabolism, vol. 51, no. 1, 2007, pp. 88–95. PubMed, doi:10.1159/000100954.
  12. Alpert, Michelle. “The Diverse Benefits of Glutathione: A Key Antioxidant for Reversing Chronic Illness.” Alternative and Complementary Therapies, vol. 11, no. 5, Oct. 2005, pp. 241–45. DOI.org (Crossref), doi:10.1089/act.2005.11.241.
  13. Pizzorno, Joseph. “Glutathione!” Integrative Medicine: A Clinician’s Journal, vol. 13, no. 1, Feb. 2014, pp. 8–12.
  14. Nielsen, Forrest H. “Effects of Magnesium Depletion on Inflammation in Chronic Disease.” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 6, Nov. 2014, pp. 525–30. PubMed, doi:10.1097/MCO.0000000000000093.
  15. Saedisomeolia, Ahmad, and Marziyeh Ashoori. “Riboflavin in Human Health: A Review of Current Evidences.” Advances in Food and Nutrition Research, vol. 83, 2018, pp. 57–81. PubMed, doi:10.1016/bs.afnr.2017.11.002.
  16. O’Leary, Fiona, and Samir Samman. “Vitamin B12 in Health and Disease.” Nutrients, vol. 2, no. 3, Mar. 2010, pp. 299–316. PubMed Central, doi:10.3390/nu2030299.
  17. Kennedy, David. “B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review.” Nutrients, vol. 8, no. 2, MDPI AG, MDPI, 2016, pp. 68–68. wfu.primo.exlibrisgroup.com, doi:10.3390/nu8020068.
  18. Goodwin, J. S., et al. “Association between Nutritional Status and Cognitive Functioning in a Healthy Elderly Population.” JAMA, vol. 249, no. 21, June 1983, pp. 2917–21.
  19. Kennedy, David O., et al. “Effects of High-Dose B Vitamin Complex with Vitamin C and Minerals on Subjective Mood and Performance in Healthy Males.” Psychopharmacology, vol. 211, no. 1, July 2010, pp. 55–68. PubMed Central, doi:10.1007/s00213-010-1870-3.